Streetbeat News

Equity Actions

GWAV

Greenwave Technology Solutions' shares surged following the announcement of regaining compliance with the Nasdaq Shareholder Equity Requirement and a $14.87 million increase in shareholder's equity, achieved through an Exchange Agreement with DWM Properties.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 5:06 pm

CLSK

CleanSpark has amended its At the Market Offering Agreement, allowing for the potential sale of up to $800 million in shares, subject to limitations on the number of authorized but unissued shares. This amendment, known as the ATM Upsized Offering, provides CleanSpark with flexibility in issuing new shares post the filing date of the Prospectus Supplement.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 4:32 pm

LULU

Financial giants have shown a bullish sentiment on Lululemon Athletica (NASDAQ:LULU) through options trading, with a notable volume of trades targeting a price range of $300 to $450. Analysis of recent options activity reveals a mix of bullish and bearish sentiments, with a slight majority leaning towards bullish. The company's stock is currently up, with analysts giving positive ratings and target prices significantly above the current market price.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 4:31 pm

WBA

Deep-pocketed investors have shown a significant interest in Walgreens Boots Alliance (NASDAQ:WBA), with a bullish sentiment prevailing in the options market. Benzinga's tracking revealed 9 extraordinary options activities, with a majority leaning bullish. The options trading suggests a price band focus between $15.0 and $27.5 for WBA. Notable options activity includes both calls and puts with varying sentiments and strike prices. Walgreens Boots Alliance, a major retail pharmacy chain in the U.S., is positioned as a one-stop healthcare provider, with its stock currently showing a neutral RSI indicator.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 4:31 pm

LYFT

Lyft has seen significant trading activity in its options market, with a notable volume of May 17 $25 calls being purchased at $0.58 each, compared to an open interest of 1230. This activity comes ahead of Lyft's earnings report, which is estimated to be released after the market closes on May 2. The reference price for Lyft's stock at the time of the option trades was $19.3.

Portfolio Pulse from Charles Gross

April 01, 2024 | 4:00 pm

VKTX

Viking Therapeutics (NYSE:VKTX) has seen a decrease in short interest, now at 11.14 million shares or 11.77% of float, down 9.25% from the last report. This decline in short interest, which represents a bullish sentiment, contrasts with the peer group average of 4.71%. The coverage time for short positions is approximately 1.18 days.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 3:45 pm

CLSK

CleanSpark amended its ATM offering agreement on March 28, 2024, enabling it to issue up to $800M of common stock or the number of authorized but unissued shares. The amendment does not obligate CleanSpark to sell any shares nor the agent to purchase any, except as separately agreed, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 3:44 pm

SRZN

Surrozen shares are trading lower following the announcement of a $192.5 million private placement of securities.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 3:27 pm

XTNT

Xtant Medical's shares dropped following the announcement of disappointing Q4 GAAP EPS results and the filing for a $150 million mixed shelf offering.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 3:06 pm

IBTX

Independent Bank Gr (NASDAQ:IBTX) has been analyzed by 5 analysts, showing a shift towards a more bullish outlook with 1 bullish and 4 somewhat bullish ratings recently. The average 12-month price target for IBTX is now $56.6, reflecting a 1.67% increase from the previous target of $55.67. Analysts' actions vary from lowering to raising price targets, indicating a dynamic view on the company's future performance. Despite facing revenue challenges with a -23.67% growth over 3 months, IBTX demonstrates strong financial health with exceptional net margin, ROE, and ROA, and a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 3:00 pm